Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Orphazyme A/S - American Depositary Shares (NQ: ORPH )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 30, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Orphazyme A/S - American Depositary Shares

< Previous 1 2 3 4 5 6 7 Next >
5 Stocks To Watch For June 21, 2021
Some of the stocks that may grab investor focus today are: Amazon.com, Inc. (NASDAQ: AMZN) will remain in focus with the company’s two-day Prime shopping event beginning... 
Via Benzinga
Michael Burry Issues Grim Warning On Cryptocurrency, Stonks: Losses Will 'Approach The Size Of Countries'
Scion Asset Management founder Michel Burry issued a series of tweets last week warning retail traders about cryptocurrencies and the so-called Stonks — the stocks unusually... 
Via Benzinga
The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs
Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries. The U.S. Federal... 
Via Benzinga
Exposures Product Safety
This Is How You Could Have Anticipated Orphazyme's Implosion
Here's what many investors missed during this biotech stock's recent run-up. 
Via The Motley Fool
Exposures Product Safety
ORPH Stock Price Falls Over 40%: Why It Happened
Orphazyme A S ADR (NASDAQ:ORPH) shares are trading lower b... 
Via Benzinga
Mid-Afternoon Market Update: Dow Tumbles Over 400 Points; CAI International Shares Spike Higher
Toward the end of trading Friday, the Dow traded down 1.27% to 33,394.86 while the NASDAQ fell 0.92% to 14,031.05. The S&P also fell, dropping 1.03% to 4,178.31. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Geron (NASDAQ:GERN) shares increased by 53.19% to $2.16 during Friday's regular session. As of 12:33 EST, Geron's stock is trading at a volume of 179.2... 
Via Benzinga
Here's Why Orphazyme Stock Is Imploding Today
The FDA didn't deliver the approval decision investors were expecting. 
Via The Motley Fool
Exposures Product Safety
Mid-Day Market Update: Crude Oil Rises Over 1%; Orphazyme Shares Plunge
Midway through trading Friday, the Dow traded down 1.13% to 33,440.28 while the NASDAQ fell 0.74% to 14,056.31. The S&P also fell, dropping 0.92% to 4,183.07. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
32 Stocks Moving In Friday's Mid-Day Session
Gainers CAI International, Inc. (NYSE: CAI) shares jumped 46.4% to $55.86 after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc. Sykes Enterprises,... 
Via Benzinga
Meme Stock Orphazyme Crashes On FDA Rejection, Slashed 2021 Outlook
Meme stock Orphazyme tanked Friday after U.S. regulators rejected its rare disease treatment, leading the Danish company to slash its 2021 outlook. 
Via Investor's Business Daily
Exposures Product Safety
Mid-Morning Market Update: Markets Open Lower; Adobe Reports Upbeat Q2 Earnings
Following the market opening Friday, the Dow traded down 1.25% to 33,401.59 while the NASDAQ fell 0.54% to 14,085.56. The S&P also fell, dropping 0.86% to 4,185.44. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
ORPH Stock: The FDA News That Has Orphazyme Plunging Today
ORPH stock is taking a plunge on Friday after the FDA told Orphazyme it needed more data on its lead drug candidate. 
Via InvestorPlace
Exposures Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers AnPac Bio-Medical Science (NASDAQ:ANPC) stock rose 21.47% to $5.26 during Friday's pre-market session. The company's market cap stands at $68.5 million.... 
Via Benzinga
The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
Exposures Product Safety
28 Stocks Moving in Friday's Pre-Market Session
Gainers CAI International, Inc. (NYSE: CAI) rose 45.1% to $55.35 in pre-market trading after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc. Geron... 
Via Benzinga
Orphazyme Wild Party At Risk As FDA Rejects Its Rare Neurodegenerative Disease Drug
Orphazyme A/S (NASDAQ: ORPH) shares, which have been extremely volatile of late, could come under pressure Friday following a regulatory setback. What Happened:... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Midatech Pharma (NASDAQ:MTP) shares moved upwards by 50.98% to $3.08 during Thursday's pre-market session. The company's market cap stands at $39.0 million... 
Via Benzinga
25 Stocks Moving in Thursday's Pre-Market Session
Gainers Midatech Pharma plc (NASDAQ: MTP) rose 42.2% to $2.90 in pre-market trading after the company disclosed breakthrough data using Q-Sphera technology. Cellect... 
Via Benzinga
48 Biggest Movers From Yesterday
Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) shares jumped 95.1% to close at $7.98 on Wednesday. Gaucho Group highlighted the launch of its Amazon Storefront. Orphazyme A/S... 
Via Benzinga
Top 3 Penny Stocks to Buy Right Now for Your 2021 Summer Watchlist
Best Penny Stocks to Watch in Summer 2021 With Summer upon us, which penny stocks are investors buying right now? Well, there are quite a few answers to this question. The first... 
Via Benzinga
PayPal And Facebook Lead The Nasdaq Lower Wednesday
U.S. indices were trading lower Wednesday afternoon after the 
Via Benzinga
Here's Why Orphazyme Shares Rocketed Higher on Wednesday
A sign there could be a buyout offer on the table sent this volatile biotech stock through the roof today. 
Via The Motley Fool
ORPH Stock: What to Know as Orphazyme Pops Again Ahead of June 17 Catalyst
Up nearly 90% today, meme stock Orphazyme is trading at sky high volume just one day ahead of an FDA review for its key drug candidate. 
Via InvestorPlace
Exposures Product Safety
A Look At Orpahzyme's Volatility Ahead Of Thursday's PDUFA Catalyst
After sobering down in the past three sessions, shares of Danish biopharma Orphazyme A/S (NASDAQ: ORPH) have taken off yet again. The Curious Case of The ‘Orphazyme Rally:... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Orphazyme (NASDAQ:ORPH) shares moved upwards by 72.49% to $17.34 during Wednesday's regular session. As of 12:31 EST, Orphazyme's stock is trading at a... 
Via Benzinga
Orphazyme Major Investor Sunstone Cut Stake After Retail Investor-Driven Rally
Orphazyme A/S’s (NASDAQ: ORPH) major shareholder Sunstone Life Science Ventures has reduced its stake following the retail investor-driven rally in the Denmark-based... 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers RAPT Therapeutics, Inc. (NASDAQ: RAPT) shares jumped 115.5% to settle at $40.02 on Monday as the company announced topline results from its Phase 1b trial of RPT193 as... 
Via Benzinga
40 Stocks Moving In Monday's Mid-Day Session
Gainers Enochian Biosciences, Inc. (NASDAQ: ENOB) shares jumped 127.2% to $10.02. The FDA has accepted Enochian BioSciences Inc's pre-IND (Investigational New Drug) request... 
Via Benzinga
Exposures Product Safety
Why Novavax, Orphazyme, Avenue Therapeutics Shares Are Moving Monday
Novavax, Inc. (NASDAQ: NVAX), Orphazyme A/S (NASDAQ: ORPH) and Avenue Therapeutics, Inc. (NASDAQ: ATXI) are among the biggest movers among biopharma stocks Monday. Novavax Finally... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.